Although functional defect mutants of CD95 or CD95L are rare in humans, the consequences of an impaired removal of pre-activated potentially dangerous cells are also characteristic for patients suffering from certain types of autoimmune lymphoproliferative syndrome (ALPS) [12,13]. This evidence concerns the gene FAS and autoimmune lymphoproliferative syndrome.